Goldman Sachs Group »

Parabilis Medicines shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $226k 8.3k 27.37

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Micron Technology CMN (MU)
Microsoft Corp CMN (MSFT)
Taiwan Semiconductor Manufac CMN (TSM)
Alphabet CMN (GOOGL)
Sandisk Corp CMN (SNDK)
Amazon CMN (AMZN)
Invesco Qqq Tr CMN (QQQ)
Broadcom CMN (AVGO)
Vaneck Etf Trust CMN (SMH)
Tesla CMN (TSLA)
Meta Platforms CMN (META)
Alphabet CMN (GOOG)

View all positions for Goldman Sachs Group

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Alphabet
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Siren
Farallon Capital Management
Jupiter Topco
Frazier Life Sciences Management
Deerfield Management Company
General Catalyst Group Management
General Atlantic

View all funds holding Parabilis Medicines